EOSINOPHILIC granuloma of the lung without associated ... Bell, for remarks on pathology of the lesions, Dr. Frank Martin, for his co-operation in the preparation of the x-ray films, Dr. William ...

In patients with eosinophilic esophagitis, etrasimod led to sustained histologic and endoscopic improvement over a year, with ...

NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

The global eosinophilic esophagitis market is on the cusp of a remarkable transformation, according to the latest comprehensive analysis released by Future Market Insights (FMI). The report forecasts ...

“Today there is hope for improved care for COPD patients with an eosinophilic phenotype, including those with a [blood eosinophil count] threshold as low as ≥150cells/μL who need new options ...

HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis ...

SAN DIEGO — Patients with eosinophilic esophagitis face significant economic burdens, according to a pair of presentations at Digestive Disease Week. These burdens may include both dollars and ...

Gerard Criner, MD, FACP, FACCP, MATINEE investigator, highlights trial results that showed reduced exacerbations and delayed disease progression in patients with eosinophilic chronic obstructive ...

Eosinophilic esophagitis (EoE) is a chronic disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. It’s related to chronic allergies to either food ...